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Takifugu rubripes is teleost ﬁsh widely used in comparative genomics to understand the human system better due to its similarities
both in number of genes and structure of genes. In this work we survey the fugu genome, and, using sensitive computational
approaches, we identify the repertoire of putative protein kinases and classify them into groups and subfamilies. The fugu genome
encodes 519 protein kinase-like sequences and this number of putative protein kinases is comparable closely to that of human.
However, in spite of its similarities to human kinases at the group level, there are diﬀerences at the subfamily level as noted in
the case of KIS and DYRK subfamilies which contribute to diﬀerences which are speciﬁc to the adaptation of the organism. Also,
certain unique domain combination of galectin domain and YkA domain suggests alternate mechanisms for immune response
and binding to lipoproteins. Lastly, an overall similarity with the MAPK pathway of humans suggests its importance to understand
signaling mechanisms in humans. Overall the fugu serves as a good model organism to understand roles of human kinases as far
as kinases such as LRRK and IRAK and their associated pathways are concerned.
1.Introduction
Takifugu rubripes is a teleost ﬁsh native to northwest paciﬁc
seas. It belongs to the family Tetraodontidae and order Tetra-
odontiformes.Thefugugenomeisrathercompactwithasize
of ∼400Mb although the number of genes is comparable to
that of higher eukaryotes indicating a considerable reduction
intheintergenicregions[1].Detailedanalysisrevealsthatthe
intron-exon boundaries [2] and in certain cases alternative
splicing [3], synteny [4, 5] have been conserved with respect
to that of humans suggesting the possibility of conserved
elements from a common ancestor. Thus, due to such fea-
tures indicating close relationship, the fugu is suggested to be
a good model organism and an eﬀective way to study evolu-
tion of structure of complex vertebrate genomes [4, 6].
In 2002, the ﬁrst draft sequence of the fugu genome
was reported by the International fugu genome Consortium
using the “whole-genome shotgun” strategy. Subsequently
many versions of the genomic data have been made available
at http://www.fugu-sg.org/. The latest version (v-5) was
released in 2010 which covers about 392Mb and 72% of
genome being organized into chromosomes.
Response to environmental stimulus via complex signal-
ing systems is a central feature of all living cells. Phosphory-
lation is one such posttranslational modiﬁcation employed
in signaling circuits which usually results in a functional2 Comparative and Functional Genomics
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Figure 1: Distribution of fugu kinases into various Hanks and Hunter groups. PKLNK: protein-kinase-like nonkinases; CAMK:
calcium/calmodulin-dependent protein kinase; CMGC: the group of cyclin-dependent protein kinase, mitogen-activated protein kinase,
glycogen synthase kinase, casein kinase-2; AGC: the group of protein kinase A, protein kinase G, protein kinase C; STE: sterile (homologs of
yeast STE); TK: tyrosine kinase; TKL: tyrosine kinase like; CK1: casein kinase 1.
change in the substrate by changing enzyme activity, cellular
location, or association with other proteins. Thus, protein
kinases have implication in regulation of various cellular
processes encompassing metabolism, stress responses, cell
cycle control, organ development, and intercellular com-
munication [28, 29]. Abnormalities in the functioning of
these kinases usually have implications in developmental
disorders and malignancies [30, 31]. The eukaryotic kinases
mainly constitute the Ser/Thr and Tyr kinases which share
a common three-dimensional fold and the catalytic core
spanning to about 300 residues [32].
The fugu genome has been used in a myriad of compar-
ative genomic studies to elucidate the function of proteins
involved in neurodegenerative diseases [33, 34], signaling
systems [35, 36], and so forth and has been suggested as a
method to elucidate cognate pathways in humans. In this
paper,usingsensitivesequenceanalysis[37–54]werecognize
therepertoireofSer/ThrandTyrkinases encodedinthefugu
genome. This is not trivial as homologous kinases are known
to be characterized by weak sequence similarity. In addition,
weclassifythesekinasesonthebasisoftheircatalyticdomain
sequenceandthedomainscovalentlytetheredtothecatalytic
kinase domain [38]. Finally, we provide comparative analysis
with distribution of the kinases in other model organisms
and other proteins of the MAPK pathway especially in
relation to the higher eukaryotes like human.
2.MaterialsandMethods
2.1.IdentiﬁcationofProteinKinases. Thec ompletesetofpr e-
dicted proteins from the ORF’s of the Takifugu rubripes ﬁfth
assembly genome has been obtained from http://www.fugu-
sg.org/. We have adopted sensitive sequence proﬁle matching
algorithms to identify and examine Ser/Thr and Tyr kinases
encoded in the genome. The protocol used is identical to
that adopted for analysis of kinases of other organisms
earlier in this laboratory [43–49]. Brieﬂy, we have employed
multiple sensitive sequence searchand analysis methods PSI-
BLAST [37], MulPSSM [39–41] involving extensive use of
RPS-BLAST [41]a n dH M M e r[ 42] which match Hidden
Markov Models (HMMs) to identify protein kinase catalytic
domain and their co-occurring domains. The criteria used to
associate a given protein kinase to a given subfamily on the
basis of its primary structure include the degree of sequence
identity greaterthan30%withmembersofknownsubfamily
of kinases and the presence of signature amino acids that
are characteristics of protein kinase subfamilies [43]w h i c h
include the glycine rich loop and catalytic aspartate of
consensus sequence HRDLKXXN. In addition, search proce-
d u r e ss u c ha sP S I - B L A S Th a v eb e e nu s e dt od e t e c ts e q u e n c e s
homologous to the kinase catalytic domain using an E-value
cutoﬀ of 0.0001 which is decided on the basis of previous
prototypic study [50]. Truncated sequences which are less
than 200 amino acids long were eliminated to arrive at a set
of 534 PK- (protein-kinase-) like sequences. The data set of
putative PK-like sequences has been obtained from the com-
pilation of hits obtained during various search procedures.
Out of these, 15 sequences lack aspartate in the catalytic
loop and, therefore,are unlikely tofunctionas kinases. These
are referred as protein-kinase-like non-kinases (PKLNKs)
[55]. These sequences were subjected to fold recognition
approach PHYRE (http://www.sbg.bio.ic.ac.uk/phyre/)[ 51,
52] to ensure that they fold like kinases. The ﬁnal number
of 519 sequences is likely to function as protein kinases. The
entire operation works stepwise with ﬁltering of sequences
at every stage in order to recognize kinases. The number of
sequences involved at various stages is depicted in Figure 1.
2.2. Classiﬁcation of Kinases into Hanks and Hunter Groups.
Hanks and Hunter have proposed classiﬁcation of kinases
based on sequence analysis [38]. In order to classify the fugu
kinases into these groups and subfamilies reverse PSI-BLAST
(RPS-BLAST) was used to search each of the 519 PK-like
sequences as a query against the database containing 2810Comparative and Functional Genomics 3
position-speciﬁc scoring matrices (PSSMs) created for the
various subgroups of protein kinases corresponding to sub-
families of kinases. A query kinase sequence was associated
to its subfamily based on the extent of sequence similarity.
Sequences with greater than 30% identity and 70% proﬁle
coverage with at least one of the members of a kinase groups
have been considered as members of the group or subfamily
concerned. CLUSTALW [53] was used to generate multiple
sequence alignment for the 519 kinases that were associated
tospeciﬁcgroups.MEGAversion4[54]wasusedt ogenerat e
the dendrogram showing various groups of protein kinases.
The sequences belonging to the group “Others” have been
clustered using another dendrogram. Also MEGA 4 [54]
has been used to cluster sequences of the kinase domain
regions of certain families from other organisms including
human,Drosophilamelanogaster,Caenorhabditiselegans,and
Saccharomyces cerevisiae.
2.3.AssignmentofDomainstoMultidomainKinases. Domain
assignments have been made for protein kinase catalytic
domain containing gene products using the HMMer method
by querying each of the kinase domain containing proteins
against the protein family HMMs available in the Pfam
database [56] and MULPSSM proﬁles [40, 41] of families
in Pfam database. Transmembrane segments were detected
using TMHMM [57].
2.4. Identiﬁcation of MAPK Pathway Proteins. Sequences
of MAPK proteins involved in the MAPK pathways in
human were obtained from KEGG pathway database http://
www.genome.jp/kegg/pathway.html [58]. The sequences
were then used as a query to search using BLAST against the
predicted protein sequences of fugu genome with an E-value
cut oﬀ of 0.0001. The hits were obtained after pruning on
the basis of coverage and percentage identity. The proteins
which did not identify any homolog were then queried with
anintegrated datasetoffugugenomeandSWISSPROTusing
PSI-BLAST[37]withanE-valuecutoﬀof0.001.Thepathway
was then generated as a network using CYTOSCAPE2.6.3
[59].
3. Results
The genome of fugu encodes 534 PK-like sequences. Of the
534 PK-like sequences 519 them possess the critical aspartate
residue at the location characteristic of catalytic base and
have at least one glycine conserved in the “glycine rich” loop
GXGXXG present in the subdomain I of the kinase catalytic
domain. A list of all these 519 sequences identiﬁed in this
work along with classiﬁcation and domain combinations are
deposited in the KinG database [43] which was developed in
this laboratory and the information is publicly available at
http://king.mbu.iisc.ernet.in/. In addition, these 519 kinases
are listed in the supplementary data ﬁle 1 in Supplementary
Material available online at doi. 10.1155/2012/258284. The
15 sequences lacking the critical aspartate are unlikely to
be functional as kinases though they are likely to adopt
the kinase fold. Though the exact roles of these PKLNK’s
(protein kinase like non kinases) is not entirely clear, such
sequences have been reported to have implications in various
signaling pathways [60]. Out of the 519 putative functional
kinases, 407 of them have an arginine residue preceding the
critical aspartate and these are called as the “RD” kinases
[48,61].Thisargininehasbeenindicatedtobetobeinvolved
in an interaction with phosphate group of a phosphorylated
sidechain in the activation loop of kinases. This interaction is
knowntobeacriticalstepinswitchingakinasefrominactive
to active state through conformational changes. Hence the
switching mechanism of these RD kinases is likely to be
mediated by phosphorylation at the activation segment in
the kinase catalytic domain.
Among the putative PKs, 135 are likely to be tyrosine
kinases and 296 are likely to be Ser/Thr kinases. 17 of the 296
Ser/Thr kinases are predicted to have membrane spanning
regions. Similarly, 50 of the tyrosine kinases are predicted to
be receptor tyrosine kinases. List of these kinases including
the information on predicted transmembrane region is
included in the supplementary data ﬁle 1.
3.1. Groupwise Distribution of Protein Kinases. The 519
kinases have been classiﬁed on the basis of the Hanks and
Hunter [38] scheme of classifying protein kinases into 7
groups with clearly deﬁned functional roles, namely, AGC
(regulated by binding of second messengers), STE (pro-
teins featuring in the MAPK signaling cascades in yeast),
CMGC (include MAPK, CDK proteins), CAMK (Cal-
cium/Calmodulin regulated kinases), CK1 (Casein kinase 1),
TK (tyrosine kinase), and TKL (tyrosine kinase like). Apart
from the 7 groups enlisted, there is yet another group which
comprises of sequences that cannot be classiﬁed into any of
the standard groups and are termed as “Other/Unclassiﬁed.”
The group-wise distribution of kinases in fugu has been
shown in Figure 2 with the TK group being most prevalent
and CK1 the least prevalent. Clustering of the sequences
of the catalytic kinase domain using BLAST-CLUST was
performed and 27 sequences are identiﬁed as outliers to
the group/subfamily concerned. A dendrogram was con-
structed without these 27 sequences or the TK group and
it resulted in clear distinct grouping of kinases (Figure 3).
Though the members belonging to the “Other/Unclassiﬁed”
group are signiﬁcantly diﬀerent from the classical groups,
clusters are observed indicating high similarity among the
sequences within a node (Figure 4). This points to the
possible emergence of newer subfamilies of protein kinases
that do not conform to the known groups [38] in the
classiﬁcation of kinases. However it is also possible that some
of these “new subfamilies” represent outliers of currently
known subfamilies. The group-wise distribution (percentage
number of sequences in each group) has been compared
with that of other model eukaryotic organisms such as
human, Drosophila melanogaster, Caenorhabditis elegans,
and Saccharomyces cerevisiae by performing similar analysis
(Figure 5 and Table 1). The distribution of kinases in fugu
is very similar to that of other eukaryotes considered and in
most cases very similar to that of humans at the group level.4 Comparative and Functional Genomics
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Figure 2: Percentage-wise distribution of fugu kinase groups. CAMK: calcium/calmodulin dependent protein kinase; CMGC: a group of
cyclin dependent protein kinase, mitogen activated protein kinase, glycogen synthase kinase and casein kinase-2; AGC: a group of protein
kinase A, protein kinase G, and protein kinase C; STE: sterile (homologs of yeast STE); TK: tyrosine kinase; TKL: tyrosine kinase like; CK1:
casein kinase 1.
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Figure 3: Dendrogram depicting clustering of fugu kinases. Abbreviations followed in the diagram are same as listed in the legend of
Figure 2.
Table 1: Distribution of kinases of fugu, yeast, human, Drosophila, C. elegans into various Hanks and Hunter groups. Numbers indicated
as percentage.
Groups Organism
Fugu Yeast Human D. melanogaster C. elegans
AGC 13.48 15.23 11.72 17.35 11.04
CMGC 17.91 20.95 19.82 16.43 15.82
CAMK 16.57 22.85 16.72 15.51 12.53
STE 7.51 13.33 8.9 8.21 6.56
CK1 1.54 3.8 1.8 5.45 19.4
TK 18.68 0 20.34 15.52 20.59
TKL 7.32 0 7.2 6.39 3.28
Others/Unclassiﬁed 16.95 26.66 13.27 15.06 10.74Comparative and Functional Genomics 5
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Figure 4: Dendrogram depicting clustering of kinases belonging to the “Other/Unclassiﬁed” group.
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Figure 5: Comparison of group wise distribution of kinases from fugu, human, yeast, Drosophila and C. elegans. Abbreviations followed in
t h eﬁ g u r ea r es a m ea sg i v e ni nt h el e g e n dt oFigure 2.
Though the group-wise distribution is quite comparable
we wanted to explore at the level of sub-families to see if
the same trend is observed. Interestingly, there are certain
subfamilies in which the representation by fugu kinases is
noticeably higher or lower than those of other model organ-
isms considered. The percentage-wise distribution of these
kinase subfamilies has been indicated in Figures 6 and 7.
Figure 6 indicates distribution of kinases for 15 subfamilies
in which fugu kinases occur in higher frequency with
DYRK being highest and those of tyrosine kinase group
generally being highly represented. Likewise Figure 7 shows
distribution of kinases for 7 subfamilies in which fugu
kinases occur at a lower frequency with CAMKK and
KIS subfamilies being least. The functions of each of the6 Comparative and Functional Genomics
Table 2: Kinase sub-families with abnormal distribution in fugu. Overall function of each of the family is also indicated.
Family Function
Highly represented families
JakA Receptor tyrosine kinase. Activates STAT involved in interferon signaling [7]
Lmr Receptor tyrosine kinase involved in apoptosis [8]
PDGFR Receptor tyrosine kinase activating factors for growth, diﬀerentiation, development [7]
Eph Receptor tyrosine kinase component of developmental pathways [9]
InsR Receptor that binds insulin and has a tyrosine-protein kinase activity [10]
PIM Phosphorylating chromatin proteins and controlling transcription [11]
CDKL Mediates phosphorylation of MECP2 [12]
Trio Guanine nucleotide exchange factors that mediate cell invasiveness [13]
DYRK Directs cellular response to stress conditions and also implicated in neuropathological
characteristics of Down’s syndrome [14, 15]
Trk Receptor for neurotrophin-3 (NT-3) [16]
Src Nonreceptor protein tyrosine kinase that plays pivotal roles in numerous cellular processes such
as proliferation, migration, and transformation [17]
VEGFR The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and
regulation of vascular permeability [18]
Sgk496 Induces both caspase-dependent apoptosis and caspase-independent cell death [19]
Trbl Interacts with MAPK kinases and regulates activation of MAP kinases [20]
Wnk Controls sodium and chloride ion transport [21]
Underrepresented families
KIS Function unknown
MLCK Calcium/calmodulin-dependent enzyme implicated in smooth muscle contraction via
phosphorylation of myosin light chains [22]
MLK Involved in the JNK pathway [23]
MAPKAPK Integrative element of signaling in both mitogen and stress responses [24]
CDK Involved in regulation of cell cycle by binding to cyclins [25]
CAMKK Calcium/calmodulin-dependent protein kinase that belongs to a proposed calcium-triggered
signaling cascade involved in a number of cellular processes [26]
Ste7 MAP2K homologous to yeast Ste7 [27]
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Figure 6: Percentage distribution of subfamilies that are overrepresented in fugu in comparison to various model organisms. JakA: janus
kinase A; InsR: insulin receptor, Lmr: lemur kinase; Trk: neurotrophic tyrosine kinase receptor type 1; PDGFR: platelet derived growth
factor receptor; Eph: ephrin receptor; VEGFR: vascular endothelial growth factor receptor; Trbl: tribbles; CDKL: cyclin-dependent kinase
like; DYRK: dual speciﬁcity tyrosine regulated kinase, Wnk: with no lysine (K)’ kinases.Comparative and Functional Genomics 7
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Figure 7: Percentage distribution of subfamilies that are under-represented in various model organisms. MLK: mixed lineage kinase;
MAPKAPK: mitogen- activated protein kinase- activated protein kinase; MLCK: myosin light chain kinase; CDK: cyclin dependent kinase;
CAMKK: calmodulin dependent protein kinase kinase; KIS: kinase interacting with stathmin; Ste7: sterile7.
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Figure 8: Dendrogram depicting clustering of kinases of CDK sub-family from fugu, human, Drosophila, and C. elegans.
proteins have been indicated in Table 2. Mutations or change
in expression levels of these proteins has been implicated in
various cancers (see the publications cited in Table 2). Also,
profound diﬀerences in the number of paralogous proteins
in two organisms could result in diverse outputs resulting
in distinct features in the molecular processes in the two
organisms [62]. The percentage distribution of each of the
subfamilies for all the organisms considered can be obtained
from Supplementary data ﬁle 2.
We have analyzed the nature of clustering of these fugu
kinases with respect to those in other organisms. For most
sub-families, fugu kinases group quite closely to those of
human and in a few cases with other organisms. A similar
trend is observed in the underrepresented sub-families with
diﬀerent clusters being observed that are not organism spe-
ciﬁc. The example of CDK subfamily is depicted in Figure 8.
In each of the clusters human kinases dominate, with
few representatives from fugu. Since paralogous proteins8 Comparative and Functional Genomics
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Figure 9: Dendrogram depicting clustering of kinases of ephrin receptor subfamily from fugu, human, Drosophila,a n dC. elegans.
perform diverse functions, their presence in large numbers
is indicative of high functional diversity [62]. Therefore,
it appears that paralogous CDKs in humans show larger
functional diversity than fugu CDKs which are fewer in
number. However, in the highly represented subfamilies of
fugu kinases, apart from the above trend few kinases cluster
separately suggesting higher divergence in a subset of DYRK
kinases. Figure 9 shows the example of ephrin receptor fam-
ily. In case of the DYRK family, 30 out of 40 kinases cluster
separately (Figure 10). We then explored if this is a ﬁsh-
speciﬁc trait. Fortunately another ﬁsh (zebraﬁsh) genome
has been sequenced and the list of zebraﬁsh kinases are
available in the KinG database [43]. However, the zebraﬁsh
has a large kinome (∼900 kinases). Analysis on these shows
that in most cases the fugu kinases do not cluster closely
with those of zebraﬁsh (supplementary data ﬁle 3). We
performed a BLAST [37] search against the SWISSPROT
database to identify the nearest homologs for these kinases in
other organisms irrespective of the genome being sequenced
fully or not. It was observed that, in the sequences which
cluster close to human kinases, the percentage identity of
those sequences with that of human counterpart is greater
than 60%. Nevertheless, the kinases belonging to the fugu-
speciﬁc cluster indicate low sequence identity with that of
human and relatively higher identity of about 40% with
that of certain lower eukaryotes like Xenopus tropicalis,
Dictyosteliumdiscoideum,andfungalspecies(supplementary
data ﬁle 4). These may be fugu-speciﬁc sequences which
are functionally divergent compared to those paralogs which
show signiﬁcant similarity to the human sequences. Similar
expansions have been seen in other organisms as well [63]
that help the organism to adapt to its environment.
3.2. Domain Combinations. The domain combinations for
all the predicted kinases of fugu are provided in supplemen-
tary data ﬁle 1. Most of the domain combinations observed
have been observed in various higher eukaryotes according
to the Pfam database [56]. However there are 2 cases with an
unusual domain combination as depicted in Figure 11.
Intheﬁrstcase,a galectinbinding domain hasbeen asso-
ciated with protein kinase domain. The galectin domain is
a carbohydrate binding domain and its function has been
attributed to regulation of immunity and inﬂammatory
responses,progressionofcancer,andinspeciﬁcdevelopmen-
tal cascades [64]. These domains may function within or
outside the cell. In this particular context, since there is no
transmembrane component or domains which localize it to
the membrane, the protein is likely to be cytosolic. This is
further corroborated by the lack of any signal peptide motifs
in this sequence which was analyzed using SignalP server
[65]. The protein kinase domain may play a regulatory role
wherein the activation state of the kinase might dictate the
binding abilities of the galectin binding domain.
The second case involves a YkyA domain tethered to
the protein kinase, CNH, PBD, PH, DMPK Coil, C1 1,
and the M protein repeats. Such a combination has been
predicted also in another closely related fresh water species
of Puﬀer ﬁsh, Tetraodon nigroviridis, however, without the
YkyA domain. The YkyA domain has been reported only
in bacterial species and is a putative lipoprotein binding
domain occurring as a single-domain protein which aids in
virulence [66]. It is likely that this protein is localized to the
membrane due to the presence of the PH domain which
is a reasonable indicator for membrane localization [67].
However, the role of YkyA in fugu is unclear.Comparative and Functional Genomics 9
Drosophila
C. elegans
Fugu Yeast
Human
Figure 10: Dendrogram depicting clustering of kinases of dual speciﬁcity tyrosine regulated kinases (DYRKs) subfamily from fugu, human,
yeast, Drosophila, and C. elegans.
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(a) ENSTRUP00000011453
Pkinase PBD YkyA M M M M M M M PBD PH CNH Pkinase C DMPK coil C1 1
(b) ENSTRUP00000041607
Figure 11: Unusual domain combinations. (a) Protein kinase tethered to a galectin binding domain. (b) Yka A domain associated with
protein kinase domain long with PBD, YkyA, M repeats, DMPK coil, C1 1, PH, CNH. PBD: P21-Rho-binding domain; C1 1: phorbol
esters/diacylglycerol binding domain; PH: pleckstrin homology.
Eight fugu kinase sequences are predicted to have two
protein kinase domains each containing all the prerequisites
for a functional kinase. This feature is distinct from that
of Janus kinase which comprises a nonfunctional kinase
domain (lacking critical aspartate) apart from a functional
kinase domain. Five of these 8 cases correspond to the AGC
group while the rest belong to the CAMK group. Such
twin kinases have been reported in other higher eukaryotes
in proteins like MAPKAP-K1 [68] wherein the C-terminal
kinase domain is regulatory in nature and is involved in the
activation of the N-terminal kinase domain. In all these 8
cases, both the kinase domains within a protein belong to
the same group and sub-family which may be indicative of a
duplication event and it may act by ﬁne-tuning the activity
levels of the protein. Interestingly, in most cases the C-
terminal protein kinase domain has lower sequence identity
to the respective groups than the N-terminal domain.
3.3. MAPK Signaling Pathway in Fugu. Given the slight
unusual distribution of fugu kinases in terms of subfamilies
we wanted to investigate the overall eﬀect on a signaling
pathway by considering distribution of all the proteins
involved(includingnonkinases)inthepathway.Althoughwe
did not observe any signiﬁcant skewing in the clustering of
the MAPK subfamily we chose to work on the MAPK path-
way as the proteins involved in this pathway are extremely
wellcharacterizedinothereukaryotes,especiallyforhumans.
Both kinases and non-kinases (including upstream factors
and downstream eﬀectors) were considered for the analyses.
Theextentofsequencesimilarityisanapproximateindicator
of the similarities of the functions of human and fugu
proteins involved in MAPK pathway. Results are depicted
pictorially in Figure 12. The cases with high sequence
identity (>30%) and coverage (>70%) (compared to human
proteins) have been represented as green boxes. These
indicate the presence of functional counterparts, which are
present in approximately 90% of the cases. Interestingly
in a few cases (represented as yellow boxes) the sequence
similarity levels reveal distant homologs suggesting diﬀer-
ences in molecular events. These include proteins which
act as ligands (FAS, TNF) and receptors (those of IL1,
TNF, and certain lipopolysaccharides) which are mainly10 Comparative and Functional Genomics
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Figure 12: Human-fugu homologs MAPK pathway. Boxes in green represent closely related homologs of human MAPK pathway proteins
present in fugu; yellow boxes indicate remote homlogs and red boxes indicate potential absence of homologs in fugu.
implicated in signaling pathways of immune system along
with few proteins of the three tier MAPK (MAPKKK,
MAPKK, MAPK) cascade. It also includes Ras and its
activating protein RasGrp. This is especially interesting
because Ras is a key component involved in GTP exchange
which is a crucial step in activating the MAPK cascades. Even
more glaringly, two proteins (IL1, CDC25b) do not have
any identiﬁed homologs in fugu. Potential absence of IL1 is
especially interesting because its absence indicates alternate
ligands which are able to bind to its receptor. The other
protein without any detectable homolog is CDC25b, which
is a phosphatase involved in activating CDK. Absence of
CDC25b may be viewed in the light of the fact that CDK
subfamily is underrepresented in the fugu genome.
4. Conclusions
The current analysis on the fugu genome indicates a kinase
repertoire of ∼3% of the total genome which is slightly
higher than an average of around 2% in the other model
organisms. All the groups of eukaryotic protein kinases are
found to be present in this genome with comparable num-
bers to that of humans. The observed distribution of few
kinase subfamilies is fugu speciﬁc. The presence of unique
domain combinations gives an insight into possibility of
new regulatory functions of kinases. Finally, the similarity
to signaling pathways in human may not only provide
aplatformforstudyingsignalingsystemsbutcanalsobeused
in kinase drug screening.
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